#United States #New York #Semler Scientific #Pomerantz LLP #SMLR

Pomerantz Law Firm Investigates Semler Scientific Inc.

The Pomerantz Law Firm, a prominent name in corporate litigation, has initiated an investigation regarding Semler Scientific Inc. (SMLR) and is seeking to represent affected investors. The focus of this investigation is the potential involvement of Semler's executives in securities fraud or other unlawful business practices.

Background of the Investigation

On March 3, 2025, the stock price of Semler Scientific experienced a significant decline of 9.4%, falling to $38.89 per share following the release of troubling news. This information emerged from Semler’s annual report, filed on February 28, 2025, which disclosed a serious risk associated with a potential complaint from the U.S. Department of Justice (DOJ). The report stated that there is a possibility of the DOJ filing a complaint or intervening in a civil lawsuit related to the False Claims Act seeking damages. This marks a critical development for the company, as it reveals ongoing investigations into its financial practices, specifically concerning claims for reimbursement involving the QuantaFlo device, designed to assess peripheral artery disease.

Previously, in July 2017, Semler received a civil investigative demand from the DOJ regarding these claims, and by February 2025, they had engaged in unsuccessful settlement discussions with the DOJ. Such actions raise significant questions about the company’s business conduct and its compliance with federal laws regulating reimbursement practices.

Seeking Justice for Investors

Pomerantz LLP is dedicated to uncovering the truth behind these claims and ensuring accountability. Investors who believe they may have suffered losses due to the company's actions are encouraged to reach out to Danielle Peyton, an attorney at Pomerantz, to discuss their rights. The firm emphasizes that protecting investor interests is paramount, particularly in situations involving possible securities fraud.

The Role of Pomerantz LLP

Founded more than 85 years ago by Abraham L. Pomerantz, a pioneer in the field of class action lawsuits, Pomerantz LLP has established a powerful reputation in corporate and securities litigation. Over the years, the firm has successfully recovered substantial damages for investors affected by fraudulent activities and will continue this legacy in representing investors of Semler Scientific.

Contact Information

Investors seeking more information or wishing to be part of the ongoing investigation can contact Pomerantz LLP at:
Email: [email protected]
Phone: 646-581-9980 ext. 7980.

Conclusion

As the investigation unfolds, it will be vital for all stakeholders to stay informed about the developments at Semler Scientific Inc. Transparency and accountability in corporate governance are essential to maintaining investor confidence and ensuring ethical business practices are upheld.

For those looking to join the class action or learn more about the potential implications of this situation, continued updates and insights from Pomerantz LLP will be available as the case develops.